Diabetes mellitus (Type 2): Clinical sciences

5,230views

Diabetes mellitus (Type 2): Clinical sciences

Watch later

Watch later

Approach to hypertension: Clinical sciences
Chest X-ray interpretation: Clinical sciences
Acute mesenteric ischemia: Clinical sciences
Aortic dissection: Clinical sciences
Cardiac tamponade: Clinical sciences
Congestive heart failure: Clinical sciences
Hypovolemic shock: Clinical sciences
Infectious endocarditis: Clinical sciences
Mitral stenosis: Clinical sciences
Pericarditis: Clinical sciences
Peripheral arterial disease and ulcers: Clinical sciences
Right heart failure: Clinical sciences
Temporal arteritis: Clinical sciences
Valvular insufficiency (regurgitation): Clinical sciences
Approach to hyperthyroidism and thyrotoxicosis: Clinical sciences
Approach to hypothyroidism: Clinical sciences
Approach to hypoglycemia: Clinical sciences
Acute pancreatitis: Clinical sciences
Cushing syndrome and Cushing disease: Clinical sciences
Adrenal insufficiency: Clinical sciences
Diabetes mellitus (Type 1): Clinical sciences
Diabetes mellitus (Type 2): Clinical sciences
Hyperosmolar hyperglycemic state: Clinical sciences
Graves disease: Clinical Sciences
Diabetic ketoacidosis: Clinical sciences
Hashimoto thyroiditis: Clinical sciences
Hyperparathyroidism: Clinical sciences
Primary aldosteronism (hyperaldosteronism): Clinical sciences
Syndrome of inappropriate antidiuretic hormone secretion: Clinical sciences
Approach to periumbilical and lower abdominal pain: Clinical sciences
Acetaminophen (Paracetamol) toxicity: Clinical sciences
Appendicitis: Clinical sciences
Cholecystitis: Clinical sciences
Choledocholithiasis and cholangitis: Clinical sciences
Diverticulitis: Clinical sciences
Hepatic encephalopathy: Clinical sciences
Hepatitis A and E: Clinical sciences
Hepatitis B: Clinical sciences
Hepatitis C: Clinical sciences
Ileus: Clinical sciences
Irritable bowel syndrome: Clinical sciences
Large bowel obstruction: Clinical sciences
Peptic ulcer disease: Clinical sciences
Small bowel obstruction: Clinical sciences
Approach to bleeding disorders (coagulopathy): Clinical sciences
Approach to bleeding disorders (thrombocytopenia): Clinical sciences
Approach to bleeding disorders (platelet dysfunction): Clinical sciences
Approach to hypercoagulable disorders: Clinical sciences
Approach to leukemia: Clinical sciences
Iron deficiency anemia: Clinical sciences
Sickle cell disease: Clinical sciences
Vitamin B12 deficiency: Clinical sciences
Basal cell carcinoma: Clinical sciences
Burns: Clinical sciences
Lyme disease: Clinical sciences
Melanoma: Clinical sciences
Necrotizing soft tissue infections: Clinical sciences
Pressure-induced skin and soft tissue injury: Clinical sciences
Approach to lymphoma: Clinical sciences
Approach to hallucinogen, inhalant, and cannabis use, intoxication, and overdose: Clinical sciences
Approach to stimulant use, intoxication, and overdose: Clinical sciences
Approach to trauma and stressor-related disorders: Clinical sciences
Opioid intoxication and overdose: Clinical sciences
Bipolar I, bipolar II, and cyclothymic disorder: Clinical sciences
Opioid use disorder: Clinical sciences
Substance use disorder: Clinical sciences
Approach to a fever in the returned traveler: Clinical sciences
Approach to a postoperative fever: Clinical sciences
Approach to acid-base disorders: Clinical sciences
Approach to a fever: Clinical sciences
Approach to hypercalcemia: Clinical sciences
Approach to hyperkalemia: Clinical sciences
Approach to hyponatremia: Clinical sciences
Approach to metabolic alkalosis: Clinical sciences
Approach to nosocomial infections: Clinical sciences
Approach to metabolic acidosis: Clinical sciences
Approach to hypernatremia: Clinical sciences
Approach to respiratory acidosis: Clinical sciences
Approach to respiratory alkalosis: Clinical sciences
Infectious mononucleosis: Clinical sciences
Obesity and metabolic syndrome: Clinical sciences
Systemic lupus erythematosus: Clinical sciences
Tuberculosis (extrapulmonary and latent): Clinical sciences
Approach to unsteadiness, gait disturbance, or falls: Clinical sciences
Myasthenia gravis: Clinical sciences
Osteoarthritis: Clinical sciences
Septic arthritis: Clinical sciences
Spinal fractures: Clinical sciences
Rheumatoid arthritis: Clinical sciences
Spinal infection and abscess: Clinical sciences
Approach to aphasia: Clinical sciences
Approach to blunt traumatic cervical spine injuries: Clinical sciences
Approach to differentiating lesions (brainstem): Clinical sciences
Approach to differentiating lesions (cerebral cortical and subcortical structures): Clinical sciences
Approach to differentiating lesions (cerebellum): Clinical sciences
Approach to differentiating lesions (motor neuron): Clinical sciences
Approach to differentiating lesions (nerve root, plexus, and peripheral nerve): Clinical sciences
Approach to differentiating lesions (spinal cord): Clinical sciences
Approach to dysarthria or dysphagia: Clinical sciences
Approach to headache or facial pain: Clinical sciences
Approach to epilepsy: Clinical sciences
Approach to increased intracranial pressure: Clinical sciences
Approach to traumatic brain injury: Clinical sciences
Acute stroke (ischemic or hemorrhagic) or TIA: Clinical sciences
Delirium: Clinical sciences
Brain death: Clinical sciences
Diabetes insipidus: Clinical sciences
Guillain-Barré syndrome: Clinical sciences
Meningitis and brain abscess: Clinical sciences
Subarachnoid hemorrhage: Clinical sciences
Approach to lower limb edema: Clinical sciences
Approach to vasculitis: Clinical sciences
Deep vein thrombosis: Clinical sciences
Venous insufficiency and ulcers: Clinical sciences
Sexually transmitted infection screening (GYN): Clinical sciences
Approach to vaginal discharge: Clinical sciences
Chlamydia trachomatis infection: Clinical sciences
Neisseria gonorrhoeae infection: Clinical sciences
Pelvic inflammatory disease: Clinical sciences
Approach to dyspnea: Clinical sciences
Approach to pneumoperitoneum and peritonitis (perforated viscus): Clinical sciences
Acute respiratory distress syndrome: Clinical sciences
Asthma in pregnancy: Clinical sciences
Airway obstruction: Clinical sciences
Atelectasis: Clinical sciences
Asthma: Clinical sciences
Community-acquired pneumonia: Clinical sciences
Empyema: Clinical sciences
Hospital-acquired and ventilator-associated pneumonia: Clinical sciences
Influenza: Clinical sciences
Pleural effusion: Clinical sciences
Pulmonary embolism: Clinical sciences
Pneumothorax: Clinical sciences
Upper respiratory tract infections: Clinical sciences
Tuberculosis (pulmonary): Clinical sciences
Approach to acute kidney injury: Clinical sciences
Catheter-associated urinary tract infection: Clinical sciences
Intrinsic acute kidney injury (glomerular causes): Clinical sciences
Chronic kidney disease: Clinical sciences
Intrinsic acute kidney injury (non-glomerular causes): Clinical sciences
Lower urinary tract infection: Clinical sciences
Postrenal acute kidney injury: Clinical sciences
Pyelonephritis: Clinical sciences
Prerenal acute kidney injury: Clinical sciences
Asthma: Information for patients and families (The Primary School)
Food allergies and EpiPens: Information for patients and families (The Primary School)
Empathetic listening for clinicians
Shared decision-making
Implicit bias
The do's and don'ts of patient care
Cardiovascular disease screening: Clinical sciences
Essential hypertension: Clinical sciences
Approach to a murmur (pediatrics): Clinical sciences
Carotid artery stenosis screening: Clinical sciences
Acute rheumatic fever and rheumatic heart disease: Clinical sciences
Randomized control trial
Clinical trials
Study designs
Bias in performing clinical studies
Problem-based learning
Sample size
Information bias
Selection bias
Case-control study
Cohort study
Hypothesis testing: One-tailed and two-tailed tests
Correlation
Paired t-test
Types of data
Bias in interpreting results of clinical studies
Two-sample t-test
The role of the kidney in acid-base balance
Anatomy of the glossopharyngeal nerve (CN IX)
Anticoagulants: Warfarin
Class I antiarrhythmics: Sodium channel blockers
Hepatitis A and Hepatitis E virus
Class IV antiarrhythmics: Calcium channel blockers and others
Anatomy clinical correlates: Oculomotor (CN III), trochlear (CN IV) and abducens (CN VI) nerves
Anatomy of the facial nerve (CN VII)
Anatomy of the vestibulocochlear nerve (CN VIII)
Anatomy clinical correlates: Glossopharyngeal (CN IX), vagus (X), spinal accessory (CN XI) and hypoglossal (CN XII) nerves
Anatomy clinical correlates: Facial (CN VII) and vestibulocochlear (CN VIII) nerves
Anatomy of the trigeminal nerve (CN V)
Anatomy of the spinal accessory (CN XI) and hypoglossal (CN XII) nerves
Anatomy of the vagus nerve (CN X)
Definitions of acids and bases
Anatomy clinical correlates: Trigeminal nerve (CN V)
Kidney stones: Pathology review
Meningitis
Cellulitis and erysipelas: Clinical sciences
Sepsis: Clinical sciences
Bacterial vaginosis: Clinical sciences
Aspiration pneumonia and pneumonitis: Clinical sciences
Clostridioides difficile infection: Clinical sciences

Decision-Making Tree

Transcript

Watch video only

Diabetes mellitus is a condition where glucose can’t be properly moved from the blood into the cells. Now, there are two types of diabetes mellitus, type 1 and type 2, and the main difference between them is the underlying mechanism. Type 2 diabetes mellitus is most commonly seen in patients with obesity, when peripheral tissue becomes resistant to insulin, which is also known as insulin resistance.

Since tissues don’t respond as well to normal insulin levels, beta cells in the pancreas ramp up their insulin production. In order to have the same effect on peripheral tissue and therefore move glucose out of the blood, and into tissue cells. Over time, beta cells become dysfunctional and can no longer secrete sufficient insulin, which eventually results in impaired insulin secretion and high blood glucose levels. This can cause clinical manifestations ranging from prediabetes, diabetes mellitus, to severe life-threatening conditions, like hyperosmolar hyperglycemic state or HHS and diabetic ketoacidosis or DKA.

Now, if you suspect type 2 diabetes mellitus, you should first perform an ABCDE assessment to determine if your patient is unstable or stable. If the patient is unstable, stabilize the airway, breathing, and circulation. This means that you might need to intubate the patient. Next, obtain IV access and, if your patient is hypotensive, start IV fluids for volume resuscitation. Finally, put your patient on continuous vital sign monitoring, such as pulse oximetry, blood pressure, and heart rate.

Next, you want to know if your unstable patient with type 2 diabetes has HHS or, less frequently, DKA. Obtain a focused history and physical exam, and order labs, such as random blood glucose, serum osmolality, BMP, urinalysis, hemoglobin A1c, as well as ABG or VBG. Your patient might be too obtunded or confused to speak, so be sure to review the chart thoroughly and speak with caretakers to get an accurate history. Some patients have a known history of diabetes, while others might not. Next, history might reveal fatigue and headaches, as well as polydipsia and polyuria. Additionally, they might have symptoms of a precipitating illness, such as fever, or a history of recent infection or disruption to their diabetes treatment plan. On the other hand, physical exam might reveal a confused, somnolent patient with tachypnea, tachycardia, or hypotension. The mucous membranes are often dry.

Next, in HHS, lab results typically reveal a significantly elevated random blood glucose, often exceeding 600 milligrams per deciliter, and a high serum osmolality, usually greater than 320 milliosmoles per liter. On the other hand, BMP may reveal electrolyte abnormalities, such as hyponatremia and hypokalemia, as well as elevated BUN and creatinine. Finally, there will be an elevated hemoglobin A1c. On the other hand, in DKA, lab results typically reveal a significantly elevated random blood glucose, typically lower than in HHS, but exceeding 250 milligrams per deciliter, and a normal serum osmolality. BMP may reveal electrolyte abnormalities, such as hyponatremia and hypokalemia, as well as elevated BUN and creatinine. Next, urinalysis could show mild ketones. Finally, there will be an elevated hemoglobin A1c, and the ABG or VBG may reveal elevated anion gap metabolic acidosis.

Now, if the patient has enough of these findings, you can diagnose HHS or DKA. Management of these individuals includes IV fluid resuscitation to correct dehydration and hyperosmolality, as well as electrolyte repletion. Additionally, you can start an IV insulin drip, if needed, and don’t forget to treat any underlying or precipitating causes!

Now that we're done with unstable patients, let’s go back to the ABCDE assessment and discuss the stable ones. If your patient is stable, first obtain a focused history and physical examination. History often reveals symptoms such as unintentional weight loss, polydipsia, polyuria, and blurred vision. Additionally, the patient might report risk factors like a sedentary lifestyle with low physical activity, age greater than 45, a family history of type 2 diabetes mellitus, or a history of gestational diabetes.

Sometimes, the only symptom a patient might report is numbness or tingling of their extremities, indicating peripheral neuropathy. The physical exam typically reveals obesity, acanthosis nigricans, and diminished sensation to pinprick in the distal extremities. In addition, if you use a thin filament to press the sole, the patient might report decreased sensation. This is referred to as abnormal monofilament testing. At this point, you should suspect type 2 diabetes mellitus, and proceed with labs, such as hemoglobin A1c, a random blood glucose, a fasting blood glucose, and sometimes an oral glucose tolerance test, or OGTT for short.

Now lets look at the results of our labs to determine a diagnosis. Now, if the hemoglobin A1c is less than 5.7%, fasting blood glucose is less than 100 mg/dL, random blood glucose is less than 200 mg/dL, and blood glucose after the 2-hour OGTT is less than 140 mg/dL, then you should consider alternative diagnoses.

On the other hand, if the hemoglobin A1c is between 5.7% and 6.5%, fasting blood glucose is between 100 mg/dL and 126 mg/dL, random blood glucose is under 200 mg/dL, or blood glucose after the 2-hour OGTT is between 140 and 199, then the patient has prediabetes. In this case, encourage lifestyle modifications, such as a healthy diet and physical activity, to decrease the risk of developing type 2 diabetes mellitus. However, if your patient is at high risk for type 2 diabetes mellitus, consider adding an oral hypoglycemic, such as metformin. You should also repeat their diabetic screening tests yearly.

Sources

  1. "Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2022" Diabetes Care (2022)
  2. "Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)" Diabetologia (2022)
  3. "Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement" JAMA (2021)
  4. "Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians" Ann Intern Med (2017)
  5. "Pathophysiology of Type 2 Diabetes Mellitus" Int J Mol Sci (2020)
  6. "Diabetes Mellitus Type 2" StatPearls Publishing (2023)